×
Hyperfine Total Liabilities 2021-2025 | HYPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hyperfine total liabilities from 2021 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Hyperfine Total Liabilities 2021-2025 | HYPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hyperfine total liabilities from 2021 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$188.5B
Thermo Fisher Scientific (TMO)
$162.6B
Edwards Lifesciences (EW)
$46.2B
Alcon (ALC)
$43.8B
IDEXX Laboratories (IDXX)
$43.5B
DexCom (DXCM)
$33.5B
IQVIA Holdings (IQV)
$28.6B
Mettler-Toledo (MTD)
$25.7B
STERIS (STE)
$22.7B
Waters (WAT)
$21B
SONOVA HOLDING (SONVY)
$17.7B
Hologic (HOLX)
$14.9B
Sysmex ADR (SSMXY)
$10.5B
Penumbra (PEN)
$9.4B
Masimo (MASI)
$9B
Globus Medical (GMED)
$7.8B
Glaukos (GKOS)
$6.1B
Teleflex (TFX)
$5.3B
Integer Holdings (ITGR)
$4.2B
TransMedics (TMDX)
$4.2B
PROCEPT BioRobotics (PRCT)
$3.3B
LivaNova (LIVN)
$2.5B
Veracyte (VCYT)
$2.2B
Nihon Kohden (NHNKY)
$2.1B
Elekta AB (EKTAY)
$2B
Alphatec Holdings (ATEC)
$1.7B
Artivion (AORT)
$1.4B
Pulse Biosciences (PLSE)
$1.2B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B